- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Amgen Inc+ Add to Watchlist
AMGN:US115.5400 USD 0.5400 0.47%
As of 20:10:00 ET on 04/16/2014.
Company Profile for Amgen Inc (AMGN)
Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.
Key Executives for Amgen Inc (AMGN)
|Robert A Bradway "Bob"Chairman/President/CEO||Anthony C Hooper "Tony"Exec VP:Global Commercial Ops|
|Madhavan BalachandranExec VP:Operations||Sean E HarperExec VP:Research & Dev|
|Brian M McNameeExec VP:Full Potential Initiatives||David J ScottSenior VP/Secy/Gen Cnsl|
|Stuart A TrossSenior VP:Human Resources||Martin VantriesteSenior VP:Quality|
|Michael A KellyVP:Intl Finance/Acting CFO||Thomas J W DittrichVP:Finance/Chief Acctg Officer|
|Arvind SoodVP:Investor Relations|